Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


CMV-hRad51 Citations (3)

Originally described in: Development of hRad51-Cas9 nickase fusions that mediate HDR without double-stranded breaks.
Rees HA, Yeh WH, Liu DR Nat Commun. 2019 May 17;10(1):2212. doi: 10.1038/s41467-019-09983-4.
PubMed Journal

Articles Citing CMV-hRad51

Novel fluorescent-based reporter cell line engineered for monitoring homologous recombination events. Bernardi A, Gobelli D, Serna J, Nawrocka P, March-Rossello G, Orduna A, Kozlowski P, Simarro M, de la Fuente MA. PLoS One. 2021 Apr 30;16(4):e0237413. doi: 10.1371/journal.pone.0237413. eCollection 2021. PubMed
Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer. Bai S, Taylor SE, Jamalruddin MA, McGonigal S, Grimley E, Yang D, Bernstein KA, Buckanovich RJ. Mol Cancer Ther. 2022 Sep 6;21(9):1473-1484. doi: 10.1158/1535-7163.MCT-21-0873. PubMed
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer. Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, Pommey S, Messaoudi N, McNicoll Y, Soucy G, Koseoglu S, Masia R, Lake AC, Seo H, Eeles CB, Rohatgi N, Robson SC, Turcotte S, Haibe-Kains B, Stagg J. Cancer Immunol Res. 2023 Jan 3;11(1):56-71. doi: 10.1158/2326-6066.CIR-22-0260. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.